Amy Paller, MD
- With the possibility that measles is on the rise, we dermatologists need to be on the lookout for children or adults coming in with the measles morbilliform rash and a history (high fever,cold symptoms,eye redness) that is suspicious for this highly contagious disease www.healio.com/news/dermato...
- Reposted by Amy Paller, MDExciting opportunity in the Peng Lab at Northwestern, focusing on stem cells, autophagy, and epithelial biology. Please share with interested candidates! postdocs.northwestern.edu/announcement... #jobSky #postdocSky #dermSky #eyeSky
- Excited that 3 organizations supporting Epidermal Differentiation Disorders are teaming to sponsor a special pre-SID program in Chicago that will include experts and patients. Hope to see you there. www.pachyonychia.org/2026-edd-sym... #DermSky #MedSky #raredisease #EDDs
- We’re excited to see our Ichthyosis community come together again! 📅 Saturday, January 17, 2026 📍 Lurie Children’s Hospital, Chicago It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together. We hope to see you there 💙
- An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds #raredisease #epdermolysisbullosa #microbiome #dermsky #medsky pubmed.ncbi.nlm.nih.gov/40803690/
- New review article! Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors doi.org/10.1016/j.ja... #dermsky #medsky
- New Treatments in Atopic Dermatitis Update #DermSky #MedSky @annalsacaai.bsky.social pubmed.ncbi.nlm.nih.gov/40562170/
- Excited to share that three of our lab members are presenting their work at # #SIDSanDiego25! Come support them at their talks and poster sessions. @siderm.bsky.social #DermSky
- Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance. #wearabledevices #DermSky A non-contact wearable device for monitoring epidermal molecular flux www.nature.com/articles/s41...
- A new classification of hereditary EDDs highlights shared disease mechanisms—unlocking targeted, pathogenesis-based treatments. From lovastatin-cholesterol to kallikrein inhibitors and gene editing, care for syndromic ichthyosis is evolving. doi.org/10.1093/bjd/... #raredisease #MedSky #DermSky
- Long-term dupilumab treatment in young children (6mo–5y) with moderate-to-severe AD shows low infection rates. This reinforces its strong safety profile for pediatric eczema care. #AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky Read more: eprints.whiterose.ac.uk/220380/
- New study on tapinarof cream 1% in pediatric AD! Minimal systemic absorption, favorable safety, and good tolerability in children (2–17 yrs)with extensive AD. The treatment was well tolerated, even on sensitive skin and flexural areas, with only mild folliculitis reported. #atopicdermatitis #dermsky
- Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting! Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society. #StandUpForScience @aadmember.bsky.social
- So proud of our amazing faculty in skin research - consistently at the top and this year #2. Go Northwestern Dermatology! #DermSky #MedSky
- Reposted by Amy Paller, MDDebra and @charitydebra.bsky.social are delighted to support a clinical trial led by @pallerlab.bsky.social @nufeinbergmed.bsky.social. The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB. Read more 👉 bit.ly/Dupilumabtot...
